Susan Whichard
Direttore/Membro del Consiglio presso Neuromod Devices Ltd.
Profilo
Susan Whichard is currently a Non-Executive Director at Neuromod Devices Ltd.
She previously worked as Vice President-Consumer & Professional Services at InSound Medical, Inc. in 2011.
Posizioni attive di Susan Whichard
| Società | Posizione | Inizio |
|---|---|---|
Neuromod Devices Ltd.
 Neuromod Devices Ltd. Medical SpecialtiesHealth Technology Neuromod Devices Ltd. operates as a medical device company which engages in the research and development of neuromodulation technologies for chronic tinnitus. The firm develops proprietary neuromodulation technologies designed to address pathologies, which are believed to give rise to illusory perceptions, such as tinnitus. These technologies utilize bi-modal neuromodulation and aim to promote positive therapeutic change within the human nervous system. The company was founded by Ross O?Neill in 2010 and is headquartered in Dublin, Ireland. | Direttore/Membro del Consiglio | 16/08/2021 |
Precedenti posizioni note di Susan Whichard
| Società | Posizione | Fine |
|---|---|---|
InSound Medical, Inc.
 InSound Medical, Inc. Medical SpecialtiesHealth Technology InSound Medical, Inc. developed and manufactured hearing devices. The company was founded in 1998 and was headquartered in Newark, CA. | Corporate Officer/Principal | 20/10/2011 |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 2 |
|---|---|
InSound Medical, Inc.
InSound Medical, Inc. Medical SpecialtiesHealth Technology InSound Medical, Inc. developed and manufactured hearing devices. The company was founded in 1998 and was headquartered in Newark, CA. | Health Technology |
Neuromod Devices Ltd.
Neuromod Devices Ltd. Medical SpecialtiesHealth Technology Neuromod Devices Ltd. operates as a medical device company which engages in the research and development of neuromodulation technologies for chronic tinnitus. The firm develops proprietary neuromodulation technologies designed to address pathologies, which are believed to give rise to illusory perceptions, such as tinnitus. These technologies utilize bi-modal neuromodulation and aim to promote positive therapeutic change within the human nervous system. The company was founded by Ross O?Neill in 2010 and is headquartered in Dublin, Ireland. | Health Technology |
- Borsa valori
- Insiders
- Susan Whichard
